489 related articles for article (PubMed ID: 16177050)
1. Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice.
Rezai-Zadeh K; Shytle D; Sun N; Mori T; Hou H; Jeanniton D; Ehrhart J; Townsend K; Zeng J; Morgan D; Hardy J; Town T; Tan J
J Neurosci; 2005 Sep; 25(38):8807-14. PubMed ID: 16177050
[TBL] [Abstract][Full Text] [Related]
2. ADAM10 activation is required for green tea (-)-epigallocatechin-3-gallate-induced alpha-secretase cleavage of amyloid precursor protein.
Obregon DF; Rezai-Zadeh K; Bai Y; Sun N; Hou H; Ehrhart J; Zeng J; Mori T; Arendash GW; Shytle D; Town T; Tan J
J Biol Chem; 2006 Jun; 281(24):16419-27. PubMed ID: 16624814
[TBL] [Abstract][Full Text] [Related]
3. Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice.
Rezai-Zadeh K; Arendash GW; Hou H; Fernandez F; Jensen M; Runfeldt M; Shytle RD; Tan J
Brain Res; 2008 Jun; 1214():177-87. PubMed ID: 18457818
[TBL] [Abstract][Full Text] [Related]
4. Octyl gallate markedly promotes anti-amyloidogenic processing of APP through estrogen receptor-mediated ADAM10 activation.
Zhang SQ; Sawmiller D; Li S; Rezai-Zadeh K; Hou H; Zhou S; Shytle D; Giunta B; Fernandez F; Mori T; Tan J
PLoS One; 2013; 8(8):e71913. PubMed ID: 23977176
[TBL] [Abstract][Full Text] [Related]
5. Combined treatment with the phenolics (-)-epigallocatechin-3-gallate and ferulic acid improves cognition and reduces Alzheimer-like pathology in mice.
Mori T; Koyama N; Tan J; Segawa T; Maeda M; Town T
J Biol Chem; 2019 Feb; 294(8):2714-2731. PubMed ID: 30563837
[TBL] [Abstract][Full Text] [Related]
6. Fish oil enhances anti-amyloidogenic properties of green tea EGCG in Tg2576 mice.
Giunta B; Hou H; Zhu Y; Salemi J; Ruscin A; Shytle RD; Tan J
Neurosci Lett; 2010 Mar; 471(3):134-8. PubMed ID: 20096749
[TBL] [Abstract][Full Text] [Related]
7. Green tea (-)-epigallocatechin-3-gallate inhibits beta-amyloid-induced cognitive dysfunction through modification of secretase activity via inhibition of ERK and NF-kappaB pathways in mice.
Lee JW; Lee YK; Ban JO; Ha TY; Yun YP; Han SB; Oh KW; Hong JT
J Nutr; 2009 Oct; 139(10):1987-93. PubMed ID: 19656855
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy with octyl gallate and ferulic acid improves cognition and neurodegeneration in a transgenic mouse model of Alzheimer's disease.
Mori T; Koyama N; Tan J; Segawa T; Maeda M; Town T
J Biol Chem; 2017 Jul; 292(27):11310-11325. PubMed ID: 28512130
[TBL] [Abstract][Full Text] [Related]
9. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotection and neurorescue against Abeta toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (-)-epigallocatechin-3-gallate.
Levites Y; Amit T; Mandel S; Youdim MB
FASEB J; 2003 May; 17(8):952-4. PubMed ID: 12670874
[TBL] [Abstract][Full Text] [Related]
11. Intranasal Lactoferrin Enhances α-Secretase-Dependent Amyloid Precursor Protein Processing via the ERK1/2-CREB and HIF-1α Pathways in an Alzheimer's Disease Mouse Model.
Guo C; Yang ZH; Zhang S; Chai R; Xue H; Zhang YH; Li JY; Wang ZY
Neuropsychopharmacology; 2017 Dec; 42(13):2504-2515. PubMed ID: 28079060
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin promotes beta-amyloid production via ADAM-10 inhibition.
Zhang S; Salemi J; Hou H; Zhu Y; Mori T; Giunta B; Obregon D; Tan J
Biochem Biophys Res Commun; 2010 Jul; 398(3):337-41. PubMed ID: 20542014
[TBL] [Abstract][Full Text] [Related]
13. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin-3-gallate Alleviates Cognitive Deficits in APP/PS1 Mice.
Bao J; Liu W; Zhou HY; Gui YR; Yang YH; Wu MJ; Xiao YF; Shang JT; Long GF; Shu XJ
Curr Med Sci; 2020 Feb; 40(1):18-27. PubMed ID: 32166661
[TBL] [Abstract][Full Text] [Related]
15. Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates beta-amyloid deposition through upregulating alpha-secretase in vivo and in vitro.
Mei Z; Zhang F; Tao L; Zheng W; Cao Y; Wang Z; Tang S; Le K; Chen S; Pi R; Liu P
Neurosci Lett; 2009 Mar; 452(2):90-5. PubMed ID: 19154776
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of dietary EGCG and voluntary exercise on behavior in an Alzheimer's disease mouse model.
Walker JM; Klakotskaia D; Ajit D; Weisman GA; Wood WG; Sun GY; Serfozo P; Simonyi A; Schachtman TR
J Alzheimers Dis; 2015; 44(2):561-72. PubMed ID: 25318545
[TBL] [Abstract][Full Text] [Related]
17. Neurorescue activity, APP regulation and amyloid-beta peptide reduction by novel multi-functional brain permeable iron- chelating- antioxidants, M-30 and green tea polyphenol, EGCG.
Avramovich-Tirosh Y; Reznichenko L; Mit T; Zheng H; Fridkin M; Weinreb O; Mandel S; Youdim MB
Curr Alzheimer Res; 2007 Sep; 4(4):403-11. PubMed ID: 17908043
[TBL] [Abstract][Full Text] [Related]
18. Green tea epigallocatechin-3-gallate (EGCG) and other flavonoids reduce Alzheimer's amyloid-induced mitochondrial dysfunction.
Dragicevic N; Smith A; Lin X; Yuan F; Copes N; Delic V; Tan J; Cao C; Shytle RD; Bradshaw PC
J Alzheimers Dis; 2011; 26(3):507-21. PubMed ID: 21694462
[TBL] [Abstract][Full Text] [Related]
19. A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model.
Postina R; Schroeder A; Dewachter I; Bohl J; Schmitt U; Kojro E; Prinzen C; Endres K; Hiemke C; Blessing M; Flamez P; Dequenne A; Godaux E; van Leuven F; Fahrenholz F
J Clin Invest; 2004 May; 113(10):1456-64. PubMed ID: 15146243
[TBL] [Abstract][Full Text] [Related]
20. Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease.
Reznichenko L; Amit T; Zheng H; Avramovich-Tirosh Y; Youdim MB; Weinreb O; Mandel S
J Neurochem; 2006 Apr; 97(2):527-36. PubMed ID: 16539659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
